Embedded Files
These resources are designed to assist healthcare workers with general opioid-related treatment practices, patient relations, and understanding of the multi-faceted aspects of opioid use and treatment. These resources are centered around providing actionable and easily accessible resources to help healthcare workers improve their practice with patients and to help address barriers to effective care while emphasizing health equity and anti-racism frameworks.
These resources are designed to assist healthcare workers with general opioid-related treatment practices, patient relations, and understanding of the multi-faceted aspects of opioid use and treatment. These resources are centered around providing actionable and easily accessible resources to help healthcare workers improve their practice with patients and to help address barriers to effective care while emphasizing health equity and anti-racism frameworks.
Table of Contents
Table of Contents
Risk Assessment in Opioid Prescribing
Risk Assessment in Opioid Prescribing
Opioid Prescribing Practices for Providers
Opioid Prescribing Practices for Providers
Opioid Tapering and Buprenorphine Prescribing Guidelines
Opioid Tapering and Buprenorphine Prescribing Guidelines
Arizona State Resources
Arizona State Resources
Buprenorphine Treatment Provider (DATA/X) Waiver and Information
Buprenorphine Treatment Provider (DATA/X) Waiver and Information
The Relationship Between Chronic Pain and Substance Use
The Relationship Between Chronic Pain and Substance Use
Naloxone Resources
Naloxone Resources
*(Workbook, Under Training Materials)
*(Workbook, Under Training Materials)
Reference List
Reference List
Risk factors in opioid prescribing. CDC. https://www.youtube.com/watch?v=g9VBbIFurZE. Published December 1, 2020. Accessed July 12, 2022.
Screening and assessment tools chart. National Institutes of Health. https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools. Published July 12, 2022. Accessed August 19, 2022.
Screening tools for adolescent substance use. National Institutes of Health. https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/screening-tools-adolescent-substance-use. Published July 12, 2022. Accessed August 19, 2022.
Opioids Prescribing Guideline Resources. cdc.gov. https://www.cdc.gov/opioids/providers/prescribing/index.html. Published June 30, 2022. Accessed July 12, 2022
CDC guideline for prescribing opioids for chronic pain, 2016. Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F65%2Frr%2Frr6501e1er.htm. Published March 18, 2016. Accessed July 13, 2022.
CDC guideline for prescribing opioids for chronic pain- 2022 Draft. Centers for Disease Control and Prevention. https://downloads.regulations.gov/CDC-2022-0024-0002/content.pdf. Published February 2022. Accessed July 13, 2022.
National Practice Guideline for the treatment of opioid use disorder . asam.org. https://www.asam.org/quality-care/clinical-guidelines/national-practice-guideline. Published 2020. Accessed August 16, 2022.
Pocket guide: Tapering opioids for chronic pain. cdc.gov. https://www.cdc.gov/drugoverdose/pdf/clinical_pocket_guide_tapering-a.pdf. Accessed July 13, 2022.
Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-term Opioid Analgesics. hhs.gov. https://www.hhs.gov/opioids/sites/default/files/2019-10/8-Page%20version__HHS%20Guidance%20for%20Dosage%20Reduction%20or%20Discontinuation%20of%20Opioids.pdf. Published September 2019. Accessed July 13, 2022.
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings. SAMHSA.org. https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/pep21-06-01-002.pdf.
ACEP BUPE Tool. acep.org. https://www.acep.org/patient-care/bupe/. Accessed August 16, 2022.
2018 Arizona Opioid Prescribing Guidelines. azdhs.org. https://www.azdhs.gov/documents/audiences/clinicians/clinical-guidelines-recommendations/prescribing-guidelines/az-opioid-prescribing-guidelines.pdf. Published 2018. Accessed July 12, 2022.
Arizona's Emergency Department Prescribing Guidelines. azdhs.org. https://www.azdhs.gov/documents/prevention/womens-childrens-health/injury-prevention/prescription-drugs/az-emergency-prescribing-guidelines.pdf. Published 2015. Accessed July 12, 2022.
ED-initiated buprenorphine – resources for Providers. CLOUD. https://www.opioidlibrary.org/external_website/ed-initiated-buprenorphine-resources-for-providers/. Accessed August 24, 2022.
Glenn M. Treating Opioid Use Disorder In The Emergency Department. lecture presented at the: https://moodle.publichealth.arizona.edu/login/index.php. Accessed November 2021.
Arizona Pain and Addiction Curriculum. AZDHS. https://www.azdhs.gov/audiences/clinicians/arizona-pain-addiction-curriculum/#continuing-education. Published 2018. Accessed August 19, 2022.
Behavioral Health Services . AHCCCS.gov. https://www.azahcccs.gov/Members/BehavioralHealthServices/. Published 2022. Accessed August 8, 2022.
Glenn M. Pain, Substance Misuse, and Treatment: Science, Practice and Prescribing Guidelines. lecture presented at the: University of Arizona ; April 14, 2021. https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=3a7628ad-08a4-4baa-84d1-ad12017871bd.
Glenn M. Pain, Substance Misuse, and Treatment: Science, Practice and Prescribing Guidelines. lecture presented at the: University of Arizona ; May, 2022.https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=2707f8c8-b61e-4728-9b4c-ae97013c9d49.
Sample informed consent form. azdhs.org. https://www.azdhs.gov/documents/audiences/clinicians/clinical-guidelines-recommendations/sample-informed-consent-form.pdf. Accessed July 12, 2022.
Sample patient agreement form. azdhs.org. https://www.azdhs.gov/documents/audiences/clinicians/clinical-guidelines-recommendations/sample-patient-agreement-form.pdf. Accessed July 12, 2022.
Apply for a DATA Waiver. SAMHSA.org. https://buprenorphine.samhsa.gov/forms/select-practitioner-type.php. Accessed July 13, 2022.
FAQs for buprenorphine waiver applicants and Certified Practitioners. SAMHSA.org. https://www.samhsa.gov/medication-assisted-treatment/become-buprenorphine-waivered-practitioner/buprenorphine-waiver-faqs. Published March 2022. Accessed July 13, 2022.
Tetsunaga T, Tetsunaga T, Nishida K, et al. Drug dependence in patients with chronic pain. Medicine. 2018;97(40). doi:10.1097/md.0000000000012748
Part 2: Co-occurring substance use disorder and physical comorbidities. National Institutes of Health. https://nida.nih.gov/publications/research-reports/common-comorbidities-substance-use-disorders/part-2-co-occurring-substance-use-disorder-physical-comorbidities. Published April 13, 2021. Accessed August 19, 2022.
Witkiewitz K, Vowles KE. Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: A critical review. Alcohol Clin Exp Res. 2018;42(3):478-488. doi:10.1111/acer.13594
Treating chronic pain without opioids. Centers for Disease Control and Prevention. https://www.cdc.gov/opioids/providers/training/non-opioid.html. Published July 5, 2022. Accessed August 19, 2022.
Volkow N, Benveniste H, McLellan AT. Use and misuse of opioids in Chronic pain. Annu Rev Med . 2018;69(1):451-465. doi:10.1146/annurev-med-011817-044739
Della Volpe K. Managing Opioid Use Disorders and Chronic Pain. Practical Pain Management. https://www.practicalpainmanagement.com/treatments/addiction-medicine/opioid-use-disorder/managing-opioid-use-disorders-chronic-pain. Published 2017. Accessed August 19, 2022
Brunner M. How does medication treatment for opioid use disorder affect pain? Addiction Technology Transfer Center (ATTC) Network. https://attcnetwork.org/node/37567. Published January 3, 2022. Accessed August 29, 2022.
Della Volpe K. Strategies for weaning opioids in patients with addiction and chronic pain. Practical Pain Management. https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/strategies-weaning-opioids-patients-opioid-use-disorder-chronic. Published 2017. Accessed August 19, 2022.
Worley MJ. Chronic pain elevates risk for opioid use during Buprenorphine Taper. Addiction Technology Transfer Center (ATTC) Network. https://attcnetwork.org/asme/chronic-pain-elevates-risk-opioid-use-during-buprenorphine-taper. Published March 1, 2017. Accessed August 29, 2022.
Adesoye A, Duncan N. Acute pain management in patients with opioid tolerance. U.S. Pharmacist. https://www.uspharmacist.com/article/acute-pain-management-in-patients-with-opioid-tolerance. Published March 17, 2017. Accessed August 22, 2022.
Quinlan J, Cox F. Acute pain management in patients with drug dependence syndrome. PAIN Reports. 2017;2(4). doi:10.1097/pr9.0000000000000611
Parsons G. Pain management in patients with a substance use disorder. The Pharmaceutical Journal. https://pharmaceutical-journal.com/article/ld/pain-management-in-patients-with-a-substance-use-disorder. Published February 12, 2021. Accessed August 22, 2022.
Naloxone. SAMHSA. https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/naloxone. Accessed August 24, 2022.
Understanding naloxone. National Harm Reduction Coalition. https://harmreduction.org/issues/overdose-prevention/overview/overdose-basics/understanding-naloxone/. Published September 8, 2020. Accessed August 24, 2022.
Naloxone Drug Facts. National Institutes of Health. https://nida.nih.gov/publications/drugfacts/naloxone. Published August 4, 2022. Accessed August 24, 2022.
Lifesaving naloxone. Centers for Disease Control and Prevention. https://www.cdc.gov/stopoverdose/naloxone/index.html. Published August 11, 2022. Accessed August 24, 2022.
Naloxone for law enforcement and emts. AREST. https://arest.learnworlds.com/course/naloxone. Accessed August 24, 2022.
Naloxone trainings. Arizona Center For Rural Health. https://crh.arizona.edu/programs/naloxone. Accessed August 24, 2022.
NaloxoneAz Home Page. NaloxoneAZ. https://naloxoneaz.com/. Published July 28, 2021. Accessed August 24, 2022.
Preventing an overdose. AHCCCS. https://www.azahcccs.gov/Members/BehavioralHealthServices/OpioidUseDisorderAndTreatment/Overdose_Prevention.html. Accessed August 24, 2022.
Arizona Rural Women's Health Network. Arizona Rural Women's Health Network. https://azrwhn.org/resources-2/opioid-use-disorder/individuals. Accessed August 24, 2022.
NEXT Distro. https://nextdistro.org/arizona. Accessed August 24, 2022.
Sonoran Prevention Works. https://spwaz.org/resources/. Accessed August 24, 2022.
Opioid Prevention: Naloxone. Arizona Department of Health Services. https://www.azdhs.gov/opioid/index.php#naloxone. Accessed August 24, 2022.
Order naloxone kits. Arizona Department of Health Services. https://docs.google.com/forms/d/e/1FAIpQLSdzjNP_qcMnuka7Y8N2rrE2toRHeDR6VuR7TDMSaVFtXTwZOQ/viewform. Accessed August 24, 2022.
Provider Clinical Support System. Providers Clinical Support System. https://pcssnow.org/about/. Published October 25, 2018. Accessed July 12, 2022.
AZDHS OAR Line Provider Page. Arizona Department of Health Services. https://www.azdhs.gov/oarline/#provider. Published 2022. Accessed August 8, 2022.
11 Indicators of Effective Addiction Treatment . recoveryanswers.org. http://www.recoveryanswers.org/assets/Poster-Indicators-of-Effective-Treatment-FV.pdf. Accessed July 12, 2022.
Substance use disorder course of recovery timeline. recoveryanswers.org. https://www.recoveryanswers.org/media/addiction-course-of-recovery-timeline/. Published May 15, 2018. Accessed July 12, 2022.
Facts and Recommendations for Health Professionals and Health Care Systems. Home | Surgeon General's Report on Alcohol, Drugs, and Health. https://addiction.surgeongeneral.gov/. Accessed July 28, 2022.
Project FUTRE. Family and Community Medicine. https://www.fcm.arizona.edu/workforce-development-program/project-futre. Published 2022. Accessed August 8, 2022.
Page updated
Report abuse